Please login to the form below

Not currently logged in

NICE backs Bayer’s Eylea as first-line BRVO treatment

Bayer Eylea aflibercept wet AMDRecommends visual impairment therapy over current laser treatment

Amgen's Kyprolis scarred by head-to-head duel with Velcade

Amgen flagFailed to show superior progression-free survival in first-line treatment trials

Pfizer decides against long-discussed break-up

Says dividing its R&D and generics businesses would disrupt rather than create value

Kite Pharma soars after positive CAR-T data in lymphoma

Looks to become first marketed CAR-T drug as phase II results pave way for US filing

Fair to medalling

Generally competent at strategic planning, how can pharma transition from acceptable to exceptional to deliver gold standard performances?

Surviving Brexit

How UK biopharma must adapt to a changing landscape

Sandoz seeks mobile-enabled health access solutions

Launches global competition inviting submissions via Facebook

Sandoz mHealth mobile health competition Novartis

Iris Pauporté joins OSE Immunotherapeutics

She becomes clinical project director at the French biotech

Transformational technology

Big data, the cloud and the value of insights

Novimmune expands senior management team

Dr Sven Zimmerman and Mylène Fleurant join the Swiss biotech

Pfizer launches app to help patients manage depression

Hopes the Moodivator app will complement treatment and support care teams

Is there an ROI on KOLs?

Can you measure return on investment (ROI) from compliant, patient-centred skills training for key opinion leaders?

Featured jobs

Subscribe to our email news alerts


Add my company

We started life as The Integrated Communications Company. Of course back then ‘integrated’ actually meant something. Today, we take it...

Latest intelligence

Artificial Intelligence: the new healthcare algorithm
The age of computers has hugely evolved, and with the emergence of effective machine learning, pattern recognition, and decision-making algorithms, Artificial Intelligence provides a revolutionary new approach to tailored healthcare....
Choosing destiny
As our market transforms, firms must choose their new business model carefully...
Market access improvements in Turkey